
Lieu de naissance
ÇATALCA
Langues
ANGLAIS
Le Docteur Pervin Korkmaz (Professeur associé) est née le 24.08.1978 à Çatalca/Istanbul. Elle a suivi ses études de médecine entre 1996 et 2002 à la Faculté de médecine de l'Université d'Istanbul. Elle a complété sa formation de spécialité entre 2002 et 2009 au sein du Département de pneumologie de la Faculté de médecine de l'Université Ege. Elle a préparé sa thèse de spécialité intitulée « Efficacité de la réhabilitation pulmonaire appliquée pendant huit semaines dans la bronchopneumopathie chronique obstructive (BPCO) » sous la direction du Professeur Ertürk Erdinç.
Après avoir accompli son service obligatoire en tant que spécialiste en pneumologie, elle a continué à exercer en tant que médecin spécialiste au sein du Département de pneumologie de la Faculté de médecine de l'Université Ege à partir de novembre 2011. En juillet 2018, elle a obtenu le titre de professeur associé (Doçent) ; la même année, elle a réussi les examens du certificat HERMES (certificat européen BOARD, European Examination in Adult Respiratory Medicine) ainsi que le certificat BOARD turc (certificat de qualification en pneumologie de Turquie).
Outre les sujets généraux de pneumologie tels que la BPCO, l'asthme, les pneumopathies interstitielles, le cancer du poumon, les bronchectasies, les infections pulmonaires et la tuberculose, elle s'est particulièrement intéressée aux infections pulmonaires chez les patients immunodéprimés, à la transplantation pulmonaire, à la mucoviscidose, à l'insuffisance respiratoire et à l'embolie pulmonaire. Elle a exercé en soins intensifs de pneumologie et a occupé le poste d'enseignante-chercheuse responsable des soins intensifs de pneumologie entre janvier 2020 et septembre 2023. Elle a exercé en tant que pneumologue au sein de l'équipe de transplantation cœur-poumon entre 2011 et septembre 2023. Elle pratique des actes interventionnels tels que la thoracentèse, la pose de cathéter dans l'espace pleural, la bronchoscopie et la bronchoscopie guidée par échographie endobronchique.
Après avoir quitté le Département de pneumologie de l'Université Ege en septembre 2023, le Docteur Pervin Korkmaz poursuit son activité à l'Hôpital universitaire Medipol Bahçelievler depuis septembre 2025.
Elle est l'auteure de 71 articles publiés dans des revues à comité de lecture nationales et internationales. Elle a rédigé 13 chapitres dans 13 ouvrages. Ses travaux ont fait l'objet de plus de 900 citations, et son indice H est de 14. Ses travaux scientifiques lui ont valu de nombreux prix lors de congrès nationaux et internationaux.
Membre de plusieurs associations professionnelles nationales et internationales, le Docteur Korkmaz a activement participé à de nombreuses études nationales et internationales, ainsi qu'à des projets soutenus par l'Organisation mondiale de la santé et le TÜBİTAK (Conseil de la recherche scientifique et technologique de Turquie). Elle poursuit sa carrière professionnelle en s'appuyant sur son bagage académique, son expérience professionnelle et une approche thérapeutique actuelle et scientifiquement fondée.
2023 - 2025
Medicana International İstanbul
2011 - 2023
Faculté de médecine de l'Université d'Ege, Département de pneumologie
2011 - 2011
Hôpital de pneumologie Aksaray Mustafa Yazıcı
2009 - 2011
Hôpital d'État d'Erzurum Oltu
2002 - 2009
Faculté de médecine de l'Université d'Ege, Département de pneumologie
2009
Faculté de Médecine de l'Université d'Ege, Pneumologie
2002
Université d'Istanbul, Faculté de Médecine d'Istanbul
1. Comparison of half-dose alteplase and LMWH in intermediate-high risk pulmonary embolism: a single-center observational study. Unat ÖSS, Korkmaz P, Çinkooğlu A, Can Ö, Soydan E, Bayraktaroğlu S, Çok G, Savaş R, Karbek Akarca F, Nalbantgil S, Çinar C, Uyar M, Demirağ K, Yağdi T, Engin Ç, Erdinç M, Bacakoğlu F. Egypt Heart J. 2025;77(1):74. 2. Nosocomial lower respiratory tract infections in patients with immunosuppression: a cohort study. Reyes LF, Sanabria-Herrera N, Nseir S, Ranzani OT, Povoa P, Diaz E, Schultz MJ, Rodríguez A, Serrano-Mayorga CC, De Pascale G, Navalesi P, Skoczynski S, Esperatti M, 7 Coelho LM, Cortegiani A, Aliberti S, Caricato A, Salzer HJF, Ceccato A, Civljak R, Soave PM, Luyt CE, Ekren PK, Rios F, Masclans JR, Marin J, Iglesias-Moles S, Nava S, Chiumello D, Bos LDJ, Artigas A, Froes F, Grimaldi D, Panigada M, Taccone FS, Antonelli M, Torres A, Martin Loeches I; European Network for ICU-Related Respiratory Infections (ENIRRIs) European Respiratory Society-Clinical Research Collaboration Investigators. Ann Intensive Care. 2025;15(1):61. 3. Eligibility of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) modulator therapies: cohort of cystic fibrosis registry of Türkiye. Akgül Erdal M, Nayır Büyükşahin H, Şen V, Ayzıt Kılınç A, Çokuğraş H, Doğan G, Yılmaz Aİ, Ünal G, Serbes M, Altıntaş DU, Arık E, Keskin Ö, Özaslan MM, Karcıoğlu O, Köse M, Başaran AE, Çakır EP, Canıtez Y, Özdemir A, Harmancı K, Uytun S, Eryılmaz Polat S, Hangül M, Yüksel H, Özcan G, Korkmaz P, Kılıç M, Gayretli Aydın ZG, Çaltepe G, Can D, Doğru S, Kartal Öztürk G, Süleyman A, Topal E, Özsezen B, Hızal M, Demirdöğen E, Ogun H, Börekçi Ş, Yazan H, Selimoğlu Şen H, Doğan Demir A, Çakır E, Şişmanlar Eyüboğlu T, Emiralioğlu N, Pekcan S, Özçelik U, Doğru D. Turk J Pediatr. 2025;67(1):22-30. 4. Factors Associated with Mortality in Nosocomial Lower Respiratory Tract Infections: An ENIRRI Analysis. Reyes LF, Torres A, Olivella-Gomez J, Ibáñez-Prada ED, Nseir S, Ranzani OT, Povoa P, Diaz E, Schultz MJ, Rodríguez AH, Serrano-Mayorga CC, De Pascale G, Navalesi P, Skoczynski S, Esperatti M, Coelho LM, Cortegiani A, Aliberti S, Caricato A, Salzer HJF, Ceccato A, Civljak R, Soave PM, Luyt CE, Korkmaz Ekren P, Rios F, Masclans JR, Marin J, Iglesias-Moles S, Nava S, Chiumello D, Bos LD, Artigas A, Froes F, Grimaldi D, Panigada M, Taccone FS, Antonelli M, Martin-Loeches I; European Network for ICU-Related Respiratory Infections (ENIRRIs) European Respiratory Society-Clinical Research Collaboration Investigators. Antibiotics (Basel). 2025;14(2):127. 5. Risk Factors for Pneumocystis jirovecii Pneumonia in Patients with Rheumatic Disease. Imren Nesil Taskiran, Pervin Korkmaz, Figen Yargucu Zihni, Adnan Yuksel Guruz, Seray Toz, Nevin Turgay, Abdullah Sayiner. J Pulm Respir Med. 2024;14(4). 6. Impact of the empirical therapy timing on the clinical progress of septic shock patients. Akyol D, Çankayalı İ, Ersel M, Demirağ K, Uyar M, Can Ö, Özçete E, Karbek-Akarca F, Yağdı T, Engin Ç, Özgiray E, Yurtseven T, Yağmur B, Nalbantgil S, Ekren P, Bozkurt D, Şirin H, Çilli F, Sezer ED, Taşbakan M, Yamazhan T, Pullukçu H, Sipahi H, Arda B, Ulusoy S, Sipahi OR. Diagn Microbiol Infect Dis. 2024;108(3):116149. 7. Comparison of clinical features of cystic fibrosis patients eligible but not on CFTR modulators to ineligible for CFTR modulators. Nayır Büyükşahin H, Emiralioğlu N, Yalçın E, Şen V, 8 Selimoğlu Şen H, Arslan H, Başkan AK, Çakır FB, Koray CF, Yılmaz Aİ, Ercan F, Altıntaş DU, Serbes M, Keskin Ö, Arık E, Gülen F, Barlık M, Karcıoğlu O, Damadoğlu E, Köse M, Ersoy A, Bingöl A, Başaran E, Çakır EP, Aslan AT, Canıtez Y, Korkmaz M, Özdemir A, Harmancı K, Soydaş ŞS, Hangül M, Yüksel H, Özcan G, Korkmaz P, Kılıç M, Gayretli Aydın ZG, Çaltepe G, Can D, Doğru S, Kartal Öztürk G, Süleyman A, Topal E, Özsezen B, Hızal M, Demirdöğen E, Ogun H, Börekçi Ş, Yazan H, Çakır E, Şişmanlar Eyüboğlu T, Çobanoğlu N, Cinel G, Pekcan S, Özçelik U, Doğru D. Pediatr Pulmonol. 2024(10):2499-2506. 8. D-PRISM: a global survey-based study to assess diagnostic and treatment approaches in pneumonia managed in intensive care. Reyes LF, Serrano-Mayorga CC, Zhang Z, Tsuji I, De Pascale G, Prieto VE, Mer M, Sheehan E, Nasa P, Zangana G, Avanti K, Tabah A, Shrestha GS, Bracht H, Fatoni AZ, Abidi K, Bin Sulaiman H, Eshwara VK, De Bus L, Hayashi Y, Korkmaz P, Ait Hssain A, Buetti N, Goh QY, Kwizera A, Koulenti D, Nielsen ND, Povoa P, Ranzani O, Rello J, Conway Morris A; D-PRISM Investigators. Crit Care. 2024;28(1):381. 9. Factors associated with pulmonary function decline of patients in the cystic fibrosis registry of Turkey: A retrospective cohort study. Emiralioğlu N, Çakır B, Sertçelik A, Yalçın E, Kiper N, Şen V, Altıntaş DU, Serbes M, Çokuğraş H, Kılınç AA, Başkan AK, Hepkaya E, Yazan H, Türel Ö, Kafi HM, Yılmaz Aİ, Ünal G, Çağlar T, Damadoğlu E, Irmak İ, Demir E, Öztürk G, Bingöl A, Başaran E, Sapan N, Aslan AT, Asfuroğlu P, Harmancı K, Köse M, Hangül M, Özdemir A, Tuğcu G, Polat SE, Özcan G, Gayretli ZG, Keskin Ö, Bilgiç S, Yüksel H, Özdoğan Ş, Topal E, Çaltepe G, Can D, Ekren PK, Kılıç M, Süleyman A, Eyüboğlu TŞ, Cinel G, Pekcan S, Çobanoğlu N, Çakır E, Özçelik U, Doğru D. Pediatr Pulmonol. 2024;59(11):2956-2966. 10. Multiple life-threatening complications in a patient who received lung transplantation due to cystic fibrosis and their management. Kececi Ozgur G, Ozdil A, Korkmaz P, Akcam Tİ. Ther Adv Pulm Crit Care Med. 2024;19:29768675241302903. doi: 10.1177/29768675241302903. 11. Predictivity of the Prognostic Nutritional Index and Systemic Inflammation Index for All-Cause In-Hospital Mortality in Geriatric and Adult COVID-19 Inpatients. Cavdar S, Savas S, Tasbakan S, Sayıner A, Basoglu O, Korkmaz P, Akcicek F. J Clin Med. 2024;13(15):4466. 12. Characteristics of co-infection and secondary infection amongst critically ill COVID-19 patients in the first two waves of the pandemic. De Corte T, Kohler K, Cecconi M, De Waele JJ, Conway Morris A; UNITE-COVID investigators (Pervin Korkmaz). Intensive Care Med. 2024;50(6):989-993. 13. European Network for ICU-Related Respiratory Infections (ENIRRIs): a multinational, prospective, cohort study of nosocomial LRTI. Martin-Loeches I, Reyes LF, Nseir S, Ranzani O, Povoa P, Diaz E, Schultz MJ, Rodríguez AH, Serrano-Mayorga CC, De Pascale G, Navalesi P, 9 Panigada M, Coelho LM, Skoczynski S, Esperatti M, Cortegiani A, Aliberti S, Caricato A, Salzer HJF, Ceccato A, Civljak R, Soave PM, Luyt CE, Ekren PK, Rios F, Masclans JR, Marin J, Iglesias-Moles S, Nava S, Chiumello D, Bos LD, Artigas A, Froes F, Grimaldi D, Taccone FS, Antonelli M, Torres A; European Network for ICU-Related Respiratory Infections (ENIRRIs) European Respiratory Society-Clinical Research Collaboration Investigators. Intensive Care Med. 2023;49(10):1212-1222. 14. Patients with cystic fibrosis who could not receive the CFTR modulator treatment: What did they lose in 1 year? Uytun S, Cinel G, Eryılmaz Polat S, Özkan Tabakçı S, Kiper N, Yalçın E, Ademhan Tural D, Özsezen B, Şen V, Selimoğlu Şen H, Ufuk Altıntaş D, Çokuğraş H, Kılınç AA, Başkan AK, Yazan H, Çollak A, Uzuner S, Ünal G, Yılmaz Aİ, Çağlar HT, Damadoğlu E, Irmak İ, Demir E, Kartal Öztürk G, Bingöl A, Başaran E, Sapan N, Canıtez Y, Tana Aslan A, Asfuroğlu P, Harmancı K, Köse M, Hangül M, Özdemir A, Çobanoğlu N, Özcan G, Keskin Ö, Yüksel H, Özdoğan Ş, Topal E, Çaltepe G, Can D, Korkmaz Ekren P, Kılıç M, Emiralioğlu N, Şişmanlar Eyüboğlu T, Pekcan S, Çakır E, Özçelik U, Doğru D. Pediatr Pulmonol. 2023;58(9):2505-2512. 15. Early mobilisation in critically ill COVID-19 patients: a subanalysis of the ESICM-initiated UNITE-COVID observational study. Kloss P, Lindholz M, Milnik A, Azoulay E, Cecconi M, Citerio G, De Corte T, Duska F, Galarza L, Greco M, Girbes ARJ, Kesecioglu J, Mellinghoff J, Ostermann M, Pellegrini M, Teboul JL, De Waele J, Wong A, Schaller SJ; ESICM UNITE COVID Investigators (Pervin Korkmaz). Ann Intensive Care. 2023;13(1):112. 16. Ertapenem plus meropenem combination treatment in carbapenem-resistant Klebsiella pneumoniae bacteremia: an analysis of 53 cases. Önal U, Akyol D, Kaya A, Başkol D, Kenanoglu B, Şanlıdağ G, Önal AU, Avşar CB, Mert M, Memetali S, Erdem HA, Bozkurt D, Şimşir A, Bozbıyık O, Kahraman Ü, Özgiray E, Korkmaz P, Çilli F, Pullukçu H, Yamazhan T, Taşbakan MI, Arda B, Ulusoy S, Sipahi OR. Eur J Clin Microbiol Infect Dis. 2023;42(10):1269-1273. 17. A Case Report of Lung Transplantation After Hematopoietic Stem Cell Transplantation and Literature Review. Ozgur GK, Aydin SK, Mammadov R, Kahraman U, Ekren PK, Ozdil A, Cagirici U. Transplant Proc. 2023;55(5):1297-1301. 18. What is the Optimal Treatment Regimen of Low-MolecularWeight Heparin in Coronavirus Disease 2019 Pneumonia? Unat ÖS, Karimov Z, Serçe Unat D, Damar G, Çağlayan P, Teymurlu F, Taşbakan MS, Korkmaz Ekren P, K. Başoğlu Ö, Sayıner A. Thorac Res Pract. 2023;25(1): 5-10. 19. Clinical characteristics of patients requiring lung transplantation referral in national cystic fibrosis registry data. Onay ZR, Eyüboğlu TŞ, Aslan AT, Gürsoy TR, Yalçın E, Kiper N, Emiralioğlu N, Şen HS, Şen V, Ünal G, Yılmaz Aİ, Kılınç AA, Çokuğraş H, Başkan AK, Yazan 10 H, Çollak A, Uzuner S, Şasihüseyinoğlu AŞ, Özcan D, Altıntaş DU, Öztürk GK, Demir E, Bingöl A, Başaran E, Çekiç Ş, Sapan N, Irmak İ, Damadoğlu E, Tuğcu GD, Polat SE, Özdemir A, Harmancı K, Kılıç G, Hangül M, Köse M, Tamay Z, Yüksel H, Özcan G, Topal E, Can D, Korkmaz P, Çaltepe G, Kılıç M, Özdoğan Ş, Çakır E, Çobanoğlu N, Pekcan S, Cinel G, Özçelik U, Doğru D. Turk J Pediatr. 2023;65(2):257-268. 20. Weaning from mechanical ventilation in intensive care units across 50 countries (WEAN SAFE): a multicentre, prospective, observational cohort study. Pham T, Heunks L, Bellani G, Madotto F, Aragao I, Beduneau G, Goligher EC, Grasselli G, Laake JH, Mancebo J, Peñuelas O, Piquilloud L, Pesenti A, Wunsch H, van Haren F, Brochard L, Laffey JG; WEAN SAFE Investigators (Pervin Korkmaz). Lancet Respir Med. 2023 Jan 20:S2213-2600(22)00449-0. doi: 10.1016/S2213-2600(22)00449-0. 21. Evaluation of Patients with COVID-19 Followed Up in Intensive Care Units in the Second Year of the Pandemic: A Multicenter Point Prevalence Study. Güngör S, Ediboğlu Ö, Yazıcıoğlu Moçin Ö, Adıgüzel N, Tuncay E, Ekiz İşcanlı İG, Er B, Karakurt Z, Turan S, Kosovalı BD, Mutlu NM, Kayar D, Gökbulut Bektaş Ş, Uysal E, Seğmen F, Alp G, Erdem D, Has Selmi N, Güven P, Özçelik Z, Ocakcıoğlu M, Yazıcı Özgür C, Yılmaz R, Bilgi Özel D, Cebeci H, Güler B, Cansever C, Çakırca M, İnceöz H, Solmaz İ, Özkan Sipahioğlu F, Aydın EM, Dayanır H, Öner SF, Karatepe U, Özen S, Boran M, Ergül DF, Kasapoğlu US, Delen LA, Toy E, Altun K, Albayrak T, Yanal H, Zaim G, Yarar V, Kılınç G, Deniz M, Özdemir E, Soylu VG, Yılmaz A, Saygılı SM, Öztürk EK, Ergan B, Eyüpoğlu S, Şahin Y, Yüksel B, Bulut A, Sarıtaş A, Yeniay H, Genç M, Kargın F, Özcan O, Karakoç E, Karaca Ü, Sözütek D, Sarı S, Şenoğlu N, Aygün H, Yiğit AC, Kavruk N, Uzan ÇA, Bıçakcıoğlu M, Solak S, Kutbay Özçelik H, Uluç K, Yıldırım İ, Arar MC, Demirel İ, Küver SU, Özgür ES, Aydın K, Erdal Dönmez G, Aygencel G, Esmaoğlu A, Sebil Aydın B, Tokur ME, Korkmaz Ekren P, Aydemir Y, Çakır Güney B, Erdil ÖY, Tünay A, Bahadır T, Uçkun S, Kocaoğlu N, Pınar HU, Kutluer Karaca N, Gültekin H, Ayvat P, Belin Özer A, Eroğlu A, Kuyrukluyıldız U, Baytar Ç, Ayoğlu H, Mızrakçı S, Metin H, Zanbak Mutlu ÖP, Yılmaz H, Tüzüner F. Thorac Res Pract. 2023;25(1):11 - 16. 22. Mortality predictors on the day of healthcare-associated Acinetobacter baumanni bacteremia in intensive care unit. Tokur ME, Korkmaz P, Alkan S, Yıldız E, Arık Ö, Renders DP, Balcı C. J Infect Dev Ctries. 2022 Sep 30;16(9):1473-1481. 23. Clinical and organizational factors associated with mortality during the peak of first COVID-19 wave: the global UNITE-COVID study. Greco M, De Corte T, Ercole A, Antonelli M, Azoulay E, Citerio G, Morris AC, De Pascale G, Duska F, Elbers P, Einav S, Forni L, Galarza L, Girbes ARJ, Grasselli G, Gusarov V, Jubb A, Kesecioglu J, Lavinio A, Delgado MCM, Mellinghoff J, Myatra SN, Ostermann M, Pellegrini M, Povoa P, Schaller SJ, Teboul JL, Wong A, De Waele 11 JJ, Cecconi M; ESICM UNITE-COVID investigators (Pervin Korkmaz). Intensive Care Med. 2022 Jun;48(6):690-705. 24. Co-infection and ICU-acquired infection in COIVD-19 ICU patients: a secondary analysis of the UNITE-COVID data set. Conway Morris A, Kohler K, De Corte T, Ercole A, De Grooth HJ, Elbers PWG, Povoa P, Morais R, Koulenti D, Jog S, Nielsen N, Jubb A, Cecconi M, De Waele J; ESICM UNITE COVID investigators (Pervin Korkmaz). Crit Care. 2022 Aug 3;26(1):236. 25. Clinical Predictors of Response to Tocilizumab: A Retrospective Multicenter Study. Ercan S, Ergan B, Özuygur SS, Korkmaz P, Taşbakan MS, Basoglu ÖK, Kerget B, Akgün M, Elbek O, Sayıner A, Kılınç O.Turk Thorac J. 2022 May;23(3):225-230. 26. The success of the Cystic Fibrosis Registry of Turkey for improvement of patient care. Asfuroglu P, Sismanlar Eyuboglu T, Aslan AT, Gursoy TR, Emiralioglu N, Yalcin E, Kiper N, Sen V, Sen HS, Altintas DU, Ozcan D, Kilinc AA, Cokugras H, Baskan AK, Yazan H, Erenberk U, Dogan G, Unal G, Yilmaz AI, Keskin O, Arik E, Kucukosmanoglu E, Irmak I, Damadoglu E, Ozturk GK, Gulen F, Basaran AE, Bingol A, Cekic S, Sapan N, Kilic G, Harmanci K, Kose M, Ozdemir A, Tugcu GD, Polat SE, Hangul M, Ozcan G, Aydin ZGG, Yuksel H, Topal E, Ozdogan S, Caltepe G, Suleyman A, Can D, Ekren PK, Bal CM, Kilic M, Cinel G, Cobanoglu N, Pekcan S, Cakir E, Ozcelik U, Dogru D. Pediatr Pulmonol. 2022;57(5):1245-1252. 27. Favipiravir for the treatment of COVID-19 pneumonia: Can we predict the response to treatment? Sayiner A, Erdem HA, Korkmaz Ekren P, Tasbakan S, Basoglu OK, Tasbakan MI, Yamazhan T, Gokengin D, Ozhan MH. J Infect Dev Ctries. 2022;16(3):422-426. 28. Clinical findings of patients with cystic fibrosis according to newborn screening results. Ramasli Gursoy T, Aslan AT, Asfuroglu P, Sismanlar Eyuboglu T, Cakir E, Cobanoglu N, Pekcan S, Cinel G, Dogru D, Ozcelik U, Yalcin E, Sen V, Ercan O, Kilinc AA, Yazan H, Altintas DU, Kartal Ozturk G, Bingol A, Sapan N, Celebioglu E, Tugcu GD, Ozdemir A, Harmanci K, Kose M, Emiralioglu N, Tamay Z, Yuksel H, Ozcan G, Topal E, Can D, Korkmaz Ekren P, Caltepe G, Kilic M, Ozdogan S. Pediatr Int. 2022 Jan;64(1):e14888. 29. The Efficacy of Hydroxychloroquine and Azithromycin Combination Therapy on Hospital Mortality in COVID 19 Pneumonia Patients. Özuygur Ermiş SS, Ergan B, Kaçmaz Başoğlu Ö, Ercan S, Korkmaz Ekren P, Kuruüzüm Z, Özhan MH, Sayiner AA, Savran Y, Sertöz ŞR, Taşbakan MS, Kilinç O, Sayiner A. Turk J Med Sci. 2021 Aug 4. doi: 10.3906/sag-2009-64. Epub ahead of print. PMID: 34344140. 30. Clinical Outcome of PCR-Negative COVID-19 Patients: A Retrospective Study. Abdullah Sayıner, Mehmet Sezai Tasbakan, Begüm Ergan, Oğuz Kılınç, Arzu Sayıner, Ruchan Sertoz, Selin Ozuygur, Selin Ercan, Yusuf Savran, Pervin Korkmaz Ekren, Özen K. Başoğlu, Mustafa H. Özhan. Turk Thorac J 2021; 22: 247-250. 12 31. Treatment of SARS-CoV-2 pneumonia with favipiravir: early results from the Ege University cohort, Turkey. Hüseyin Aytaç Erdem, Pervin Korkmaz Ekren, Derya Çağlayan, Meltem Taşbakan, Tansu Yamazhan, Mehmet Sezai Taşbakan, Abdullah Sayiner, Ayşe Deniz Gökengin. Turk J Med Sci. 2020 Nov 25. doi: 10.3906/sag-2008-33. 32. Türkiye’de yoğun bakım ünitelerinde hekimin mortaliteyi öngörebilme gücü. Mehtap Pehlivanlar Küçük, Tevfik Özlü, Ahmet Oğuzhan Küçük, Akın Kaya, Cenk Kıraklı, Özlem Şengören Dikiş, Hale Kefeli Çelik, Serdar Özkan, Hayriye Bektaş Aksoy, Onur Palabıyık, Mustafa Çörtük, Recai Ergün, Betül Kozanhan, Özlem Erçen Diken, Feza Bacakoğlu, Süheyla Uzun Kaya, İskender Aksoy, Hakan Cinemre, Avşar Zerman, Işıl Özkoçak Turan, Nevin Fazlıoğlu, Fatma Yıldırım, Ersin Günay, Belgin Akan, Hüseyin Arpağ, Cengizhan Sezgi, Murat Yalçınsoy, Selen Karaoğlanoğlu, Abidin Şehitoğulları, Sertaç Arslan, Yusuf Aydemir, Ayperi Öztürk, İclal Hocanlı, Musa Salmanoğlu, Aydanur Ekici, Sena Ataman, Özlem Edipoğlu, Tekin Yıldız, Zahide Doğanay, Celalettin Dağlı, Esra Arslan Aksu, Burçak Zıtounı, Ayşe İlksen Eğilmez, Yeliz Şahiner, Pervin Korkmaz Ekren, Handan İnönü Köseoğlu, ,Ahmet Baydın, Ahmet Nalbant, Davut Aydın, Ahmet Bindal, Şener Balas, Şule Esen Karamişe, Ömer Araz, Türkan Acar, Hasan Kahraman, Melike Demir, Cengiz Burnik, Ebru Çanakçı, Cahit Bilgin, Özgür Yağan, Semih Aydemir, Yalçın Önem, Zerrin Gürel Durmuş. Tuberk Toraks 2020;68(3):205-217. 33. Communication: The Follow-Up of Biomarkers Better Predicts the Poor Outcome in COVID-19 Patients. Ozen K. Basoglu, Mustafa Hikmet Ozhan, Pervin Korkmaz Ekren, Gunes Ak, Mehmet Sezai Tasbakan, Abdullah Sayiner. Annals of Clinical & Laboratory Science. 2020: 50 (6); 848-851. 34. Patients eligible formodulator drugs: Data fromcystic fibrosis registry of Turkey. Nazan Çobanoğlu, Uğur Özçelik, Erkan Çakır, Tuğba Şişmanlar Eyüboğlu. Sevgi Pekcan, Güzin Cinel, Ebru Yalçın, Nural Kiper, Nagehan Emiralioğlu, Velat Şen, Hadice Selimoğlu Şen, Ömür Ercan NP, Haluk Çokuğraş, Ayşe Ayzıt Kılınç, Lina Muhammed Al Shadfan, Hakan Yazan, Derya Ufuk Altıntaş, Dilek Karagöz, Esen Demir, Gökçen Kartal Öztürk, Ayşen Bingöl, Abdurrahman Erdem Başaran, Nihat Sapan, Şükrü Çekiç, Ebru Çelebioğlu, Ayşe Tana Aslan, Tuğba Ramaslı Gürsoy, Gökçen Tuğcu, Ali Özdemir, Koray Harmancı, Gonca Kılıç Yıldırım, Mehmet Köse, Melih Hangül, Zeynep Tamay, Ayşe Süleyman, Hasan Yüksel, Özge Yılmaz, Gizem Özcan, Erdem Topal, Demet Can, Pervin Korkmaz Ekren, Gönül Çaltepe, Mehmet Kılıç, Şebnem Özdoğan, Deniz Doğru. Pediatric Pulmonology. 2020;55:2302–2306. 35. Association between the low percentage of forced vital capacity and increased mortality after left ventricular assist device implantation. Pervin Korkmaz Ekren, Pelin Öztürk, Serkan Ertugay, 13 Ali Özdil, Sanem Nalbantgil, Çağatay Engin, Tahir Yağdı, Mustafa Özbaran. Turkish Journal of Thoracic and Cardiovascular Surgery 2020;28(4):576-585. 36. Can we predict patients that will not benefit from invasive mechanical ventilation? A novel scoring system in intensive care: the IMV Mortality Prediction Score (IMPRES). Tevfik Özlü, Mehtap Pehlivanlar Küçük, Akın Kaya, Esra Yarar, Cenk Kıraklı, Özlem Şengören Dikiş, Hale Kefeli Çelik, Serdar Özkan, Hayriye Bektaş Aksoy, Ahmet Oğuzhan Küçük, Imvıcap Study Group (Pervin Korkmaz). Turk J Med Sci. (2019) 49: 1662-1673. doi:10.3906/sag-1904-96. 37. Current Statement of Intensive Care Units in Turkey: Data obtained from 67 Centers. Ediboğlu Ö, Moçin ÖY, Özyılmaz E, Saltürk C, Önalan T, Seydaoğlu G, Çelikel T, Arıkan H, Ataman S, Kıraklı C, Özçelik Z, Kultufan S, Kara İ, Kara A, Dağlı E, Bülbül SD, Kahveci K, Dinçer M, Şenoğlu N, Özkarakaş H, Bahar İ, Cengiz M, Ramazanoğlu A, Çelik B, Gaygısız Ü, Kır G, Bindal A, Akan B, Turan IÖ, Yıldırım F, Başarık B, Ulukan ZA, Efe S, Sungur M, Temel Ş, İzdeş S, Hoşgün D, Karadeniz N, Tuncay E, Gökşenoğlu NÇ, Irmak İ, Datlı U, Zerman A, Akdağ D, Özdemir L, Elay G, Karaçayır Y, Topeli A, Hancı P, Kaya EK, Güven P, Sazak H, Aydemir S, Aygencel G, Aydemir Y, Doğanay Z, Kömürcü Ö, Hancı V, Karakoç E, Sözütek D, Coşkun G, Ateş G, Tiryaki C, Soytürk AN, Girgin NK, Çalışkan G, Bıyıklı O, Gökmen N, Koca U, Çiledağ A, Süner KÖ, Cinel İ, Arslantaş MK, Gül F, Ergün R, Yılmaz N, Altıntaş D, Talan L, Yalçınsoy M, Güllü MN, Özcan PE, Orhun G, Savran Y, Tokur ME, Akpınar S, Şen P, Gürsel G, Şerifoğlu İ, Gedik E, Balbay ÖA, Akbaş T, Cesur S, Yolacan H, Sağmen SB, Ekren PK, Bacakoğlu F, Ergan B, Günay E, Sarıaydın M, Sağlam DA, Karakurt S, Eryüksel E, Öztuna F, Mürtezaoğlu ESA, Cinemre H, Nalbant A, Yağmur Kaya Ö, Mandal T, İkidağ B. Turk Thorac J. 2018 Sep 13. doi: 10.5152/TurkThoracJ.2018.170104. 38. The association between Cytomegalovirus co-infection with Pneumocystis pneumonia and mortality in immunocompromised non-HIV patients. Korkmaz Ekren P, Töreyin ZN, Nahid P, Doskaya M, Caner A, Turgay N, Zeytinoglu A, Toz S, Bacakoglu F, Guruz Y, Erensoy S. Clin Respir J. 2018 Nov;12(11):2590-2597. 39. Evaluatıon of Traffıc Accıdent Risk in City Bus Drivers: The Use of Berlın Questıonnaıre. Mehmet Sezai Taşbakan, Pervin Korkmaz Ekren, Funda Elmas Uysal, Özen Kaçmaz Başoğlu. Turk Thorac J. 2018 Apr;19(2):73-76. doi: 10.5152/TurkThoracJ.2018.17080. 40. The Effects of Pulmonary Rehabilitation in Patients With Mild to Moderate COPD: The Bottom of An Iceberg. Pervin Korkmaz Ekren, Alev Gurgun, Funda Elmas Uysal, Senay Tuncel, Samı Denız, Hale Üzümcügil Karapolat, Feza Bacakoğlu. Turk J Phys Med Rehab 2018;64(2):162 169 DOI: 10.5606/tftrd.2018.1006. 41. Evaluation of the 2016 Infectious Diseases Society of America/American Thoracic Society Guideline Criteria for Risk of Multi-drug Resistant Pathogens in Hospital-acquired and 14 Ventilator-associated Pneumonia Patients in the Intensive Care Unit. Ekren PK, Ranzani OT, Ceccato A, Li Bassi G, Muñoz Conejero E, Ferrer M, Niederman MS, Torres A. Am J Respir Crit Care Med.2018 Mar 15;197(6):826-830. doi: 10.1164/rccm.201708-1717LE. 42. A comparison of two endoscopic posterior cordotomy techniques: Laser cordotomy vs diathermy-assisted cordotomy. Ozturk K, Turhal G, Kaya I, Aysel A, Benzer M, Korkmaz Ekren P, Akyildiz S. Clin Otolaryngol. 2018 Feb;43(1):256-260. doi:10.1111/coa.12953. 43. Barotrauma Associated with Mechanical Ventilation. Funda Elmas Uysal, Pervin Korkmaz Ekren, Atilla Kuntman, Feza Bacakoğlu. Yoğun Bakım Derg 2017; 8: 39-43. 44. Evaluation of Nephrotoxicity and Prognosis in Patients Treated with Colistin due to Hospital acquired Pneumonia. Pervin Korkmaz Ekren, Zehra Nur Töreyin, Huriye Berk Takır, Merih Kalamanoğlu Balcı, Ümmügülsüm Gaygısız, Gül Gürsel, Begüm Ergan, Aslıhan Yalçın, Cüneyt Saltürk, Müge Aydoğdu, Recai Ergün, Pınar Güven, Gaye Ulubay, Aslıhan Gürün Kaya, Aygül Çeltik, Hatice Uluer, Feza Bacakoğlu, Abdullah Sayıner. Tuberk Toraks 2017;65(4):271-281. Doi:10.5578/tt.59748. 45. Conjunctival Biopsy as a First Choice to Confirm a Diagnosis of Sarcoidosis. Pervin Korkmaz Ekren, Nesrin Mogulkoc, Zehra Nur Toreyin, Sait Egrilmez, Ali Veral, Taner Akalın, Feza Bacakoglu. Sarcoidosis Vasc Diffuse Lung Dis. 2016 Oct 7;33(3):196-200. PubMed PMID: 27758983. 46. Can fiberoptic bronchoscopy be applied to critically ill patients treated with noninvasive ventilation for acute respiratory distress syndrome? Prospective observational study. Pervin Korkmaz Ekren, Burcu Basarik Aydogan; Alev Gurgun, Mehmet Sezai Tasbakan, Feza Bacakoglu; Stefano Nava. BMC Pulm Med. 2016 May 31;16(1):89. DOI: 10.1186/s12890-016 0236-y PULM-D-16-00045R3. 47. The Role of Aerolized Colistin in the Treatment of Hospital-Acquired Pneumonia: Experience of Multicenter From Turkey. Letters to the Editor. Korkmaz Ekren P, Toreyin N, Sayiner A, Bacakoglu F; Colistin Study Group. Crit Care Med. 2016;44(5):e304. 48. Approach of pulmonologists in Turkey to noninvasive mechanical ventilation use at home for chronic respiratory failure. Özsancak Uğurlu A, Berk Takır H, Ergan B, İn E, Özyilmaz E, Ertan Edipoğlu Ö, Acartürk E, Güleç Balbay E, Görek Dilektaşlı A, Kıvanç T, Korkmaz Ekren P, Sarınç Ulaşlı S, Doğrul I, Yılmazel Uçar E, Olgun Ş, Devran Ö, Ergun R, Karakurt Z. Tuberk Toraks. 2016 Mar;64(1):1-8. 49. Approach of pulmonologists in Turkey to noninvasive mechanical ventilation use in acute respiratory failure. Özsancak Uğurlu A, Ergan B, Berk Takır H, İn E, Özyılmaz E, Ertan Edipoğlu Ö, Acartürk E, Güleç Balbay E, Görek Dilektaşlı A, Kıvanç T, Korkmaz Ekren P, Sarınç Ulaşlı 15 S, Doğrul I, Yılmazel Uçar E, Olgun Ş, Devran Ö, Ergun R, Karakurt Z. Tuberk Toraks. 2015; 63(4): 213-225. 50. A comparison of maximal oxygen uptake obtained from different tests in chronic obstructive pulmonary disease patients. (KOAH’lı Hastalarda Farklı Yöntemlerle Saptanan Maksimal Oksijen Tüketim Kapasitesinin Karşılaştırılması.) Pervin Korkmaz Ekren, Alev Gürgün, Hale Karapolat, Pelin Özdemir, Nur Töreyin, Sezai Taşbakan, Özen Kaçmaz Başoğlu, Feza Bacakoğlu. Türk Göğüs Kalp Damar Cerrahisi Dergisi 2014; 22 (1): 088-094. 51. The role of endotracheal aspiration in the diagnosis of ventilator associated pneumonia. (Ventilatörle ilişkili pnömoni tanısında endotrakeal aspiratın değeri.) Alev Gürgün, Pervin Korkmaz Ekren, Feza Bacakoğlu, Özen Kaçmaz Başoğlu, Nigar Dirican, Şöhret Aydemir, Deniz Nart, Abdullah Sayıner. Tuberk Toraks 2013; 61(4): 288-294. 52. Pulmonary rehabilitation response in elderly and younger patients with chronic obstructive pulmonary disease. (Pulmoner Rehabilitasyonun Kronik Obstrüktif Akciğer Hastalığı Olan Yaşlı ve Genç Hastalardaki Sonuçları.) Alev Gürgün, Pervin Korkmaz Ekren, Hale Karapolat, Şenay Çitim. Turkish Journal of Geriatrics 2013; 16(4): 427-433. 53. The Factors Affecting Non-Invasive Mechanical Ventilation Failure in COPD exacerbations. Bacakoglu F, M.S. Tasbakan, OK. Basoğlu, T. Oz, S. Urkmez, M. Midilli, PK. Ekren, A. Gürgün. Turk J Med Sci 2012; 42 (1):103-112. 54. Hemophagocytic Syndrome due to Lung Infection: A Case Report. (Akciğer Enfeksiyonuna Bağlı Gelişen Hemofagositik Sendrom: Olgu Sunumu.) Korkmaz Erken P, Ergin E, Göksel G, Özsan N, Hekimgil M. Tuberkuloz ve Toraks Dergisi 2011; 59(4): 374-379. 55. Changes in Recognition of Cigarette Brand Names and Logos Among Primary School Children in Two Years. (İlköğretim Çağındaki Çocuklarda Sigara Ad ve Logosunu Tanıma Oranlarında İki Yıllık Sürede Saptanan Farklılık.) Korkmaz Ekren P, Başarık B, Hikmet Özhan M. Solunum 2011;13(2): 86–90. 56. Comparison of bronchoalveolar lavage and mini-bronchoalveolar lavage in the diagnosis of pneumonia in immunocompromised patients. Tasbakan MS, Gurgun A, Basoglu OK, Ekren PK, Pullukcu H, Bacakoglu F. Respiration. 2011;81(3):229-35. doi: 10.1159/000323176. 2011;81(3):229-35. 57. The Effect of Short-Term Pulmonary Rehabilitation on Pulmonary Function Tests, Blood Gases, Functional Capacity, Dyspnea, Quality of Life and Psychological Symptoms in Chronic Pulmonary Diseases: A Retrospective Study. (Kronik Pulmoner Hastalıklarda Kısa Dönem Pulmoner Rehabilitasyonun Pulmoner Fonksiyon Testleri, Kan Gazı, Fonksiyonel Kapasite, Dispne, Yaşam Kalitesi ve Psikolojik Semptomlar Üzerine Etkisi: Retrospektif Çalışma.) 16 Karapolat H, Gurgu A, Eyigö S, Korkmaz Ekren P, Kirazlı Y. Türk Fiz Tıp Rehab Dergisi 2010;56(1):6-10. 58. An unusual presentation of anti-Jo-1 syndrome, mimicking lung metastases, with massive pleural and pericardial effusions. Mogulkoc N, Kabasakal Y, Ekren PK, Bishop PW. J Clin Rheumatol. 2006 Apr;12(2):90-